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was arbitrarily assigned to clusters comprising types 
showing ~80% identity. Methicillin resistence was 
detected by mecA gene PCR. 
Results: A total of 224 CONS isolates was included. Five 
clusters containing at least 10 isolates were identified, 
comprising strains isolated over a period of 4 to 11 years. 
The largest cluster (A) comprised 33 isolates showing 
>90% identity that were collected over a period of 4 
years (1997-2001). Cluster B (18 isolates) persisted for 
8 years, cluster C (13 isolates) for 11 years. A remarkable 
dynamic behaviour of the various clusters was observed, 
with cluster C most prominent in 1995 (6 isolates ), but 
waning subsequently, while cluster B emerged in 1993 
and persisted more or less continuously with 2 to 6 
isolates every year. Cluster A emerged in 1997 with 3 
isolates and increased strongly in subsequent years 
comprising no less than 20 of 66 blood isolates (30%) 
in 2001. Altogether, the contribution of these five 
clusters to the total of CONS blood isolates increased 
from 2/34 isolates in 1991 (6%) to 39/66 isolates in 2001 
(59%). Carriage of the mecA gene was consistently high, 
slightly fluctuating from 75% in 1991 to 91% in ‘1995 and 
1999, with no clear pattern. 
Conclusions: CONS blood isolates from the NICU 
tend to aggregate into large clusters that show either a 
“waxing and waning” or “persistently present” behaviour. 
Factors governing this behaviour are presently unknown, 
but methicillin resistance is probably not a driving force, 
as the majority of isolates carry the mecA gene. 
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Background: Previous meta-analysis of tests, up to 1995, 
for diagnosis of neonatal sepsis assessed C-reactive pro- 
tein and hematological indicators (Fowlie P. and Schmidt 
B., 1998). 
Objective: To perform a systematic review to examine 
the accuracy of newer laboratory tests for the diagnosis 
of bacterial infection in newborns. 
Methods: MEDLINE search (1995-2001) using 
keywords ‘Newborn’, ‘Infection’, ‘Sepsis’, and ‘Diag- 
nosis’. Inclusion criteria - (1) studies of infants less than 
90 days of age 2) a proven bacterial growth from a sterile 
site. Exclusion criteria - (1) amniotic fluid or other 
antenatal tests 2) studies where antenatal and neonatal 
infection data were inseparable. Relevant data were 
extracted in order to calculate likelihood ratios for 
each test where adequate raw data was provided. Two 
independent reviewers selected and reviewed each 
article. All differences were resolved by consensus. 
Results: Ninety-one citations were retrieved.Thirty-four 
articles met the inclusion criteria (Inter observer agree- 
ment Kappa=O.75). Fifteen studies met the highest 
methodological criteria (ability to distinguish true 
bacterial infection from clinical sepsis), evaluating 
eleven different tests (PCT, PCR, IL-6, IL-lbeta, NCD- 
llb, IL-lra, S-ICAM, IL-8, E alpha-lP1, TNF-alpha, 
TNF r-p55 ~75). The most commonly reported test was 
interleukin-6 (IL-6) in 7 studies. The remaining tests 
were described in no more than three studies. The 
positive likelihood ratios for individual tests ranged 
from 1.5 to 03 Nine individual papers evaluating 6 tests 
had likelihood ratios greater than 10 (12.5 to 00 (PCT, 
IL-6, IL-8, IL-lRA, E alpha-lPI, NCD-lib). The 
combination of tests also had a wide range (likelihood 
ratio 3.4 to 9.9). All studies were performed in single 
centres and had small sample sizes. 
Conclusions:Very few methodologically rigorous studies 
were found: in a significant proportion, the accuracy of 
the tests could not be independently determined due to 
lack of adequate data. There was marked heterogeneity 
in selecting the subject population and employing cut 
off levels for the tests. A few tests are promising, but 
there is insufficient data to employ them as clinical 
discriminators. 
A necrotizing enterocolitis outbreak associated with 
a novel Clostridium species in a neonatal intensive 
care unit 
G. K. M. Harding, tz2* D. Robson,’ M. Davi,‘s2 
K. Bernard,3 P Van Caeseele,tj2 M. .I. Alfa’j2 
St. Boniface General Hospital,‘* University of 
Manitoba,2* Canadian Science Centre for Human and 
Animal Health (CSCHAH),3 Winnipeg, Canada 
Background: Necrotizing enterocolitis (NEC) is a 
gastrointestinal disease with high mortality (20.40%). It 
is most commonly associated with premature neonates. 
An outbreak of NEC occurred in 6 neonates during 
November and December 2000. 
Objective: To determine the etiology of this outbreak, 
since microbial overgrowth in the gut is thought to con- 
tribute to the pathogenesis of NEC. 
Methods: Stool samples and rectal swabs were inocu- 
lated onto pre-reduced blood agar supplemented with 
Vitamin K and Hemin (BAK) plates and incubated at 
37°C in an anaerobic chamber. Blood cultures were also 
obtained and cultured in BacT/Alert Pediatric bottles. 
A point-prevalence survey of all neonates in the nursery 
was also done. Suspected clostridial colonies were 
isolated for purity and were initially identified using the 
Anident rapid anaerobe identification strips. Subsequent 
biochemical, cellular fatty acid analysis and 16SrDNA 
analysis were performed at the national reference 
laboratory (CSCHAH). 
Results: Blood cultures from three neonates grew a 
similar Clostridium species that was identified as 
Clostridium clostridioforme (Anident code 6320210) 
which we had never isolated from blood cultures of 
children and adults previously. Therefore, we submitted 
the isolates to the CSCHAH.They identified it as a novel 
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species which was named Clostridium neonataie. The 
point-prevalence survey also revealed that 5 of 24 
neonates had C neonatale in their stool. Clonality of 
the C neonatale isolates from the outbreak and the 
point-prevalence survey were confirmed by PFGE. All 
showed identical banding patterns. The organism has 
been deposited with the ATCC (#BAA-265) and with the 
CCUG (#46077). The C neonatale is a strong fermenter 
of lactose with lactic acid as a major end product and 
moderate amounts of butyric and acetic acids. It digests 
milk with gas and butyric acid production which fit recent 
suggestions that these characteristics are necessary for an 
organism to stimulate the development of NEC. Five of 
the six neonates were 235 weeks gestation which may 
explain the low mortality rate (1 of 6). 
Conclusions: We describe an outbreak of NEC 
associated with a novel species, C.neonatale; we suggest 
that in larger neonates, carriage of this Clostridium 
species may be a necessary first step in the multistage 
pathogenesis of NEC. 
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Objective: It has been shown that IgG given intra- 
venously (IVIG) as well as plasma derived IgA 
delivered orally offer protection to the very low birth 
weight infant (VLBW, < 15OOg) against necrotizing 
enterocolitis (NEC) and, in the case of IVIG, against late 
onset neonatal sepsis. It has been reported in the 
literature that mother’s milk offers similar protection. 
The objective of this study was to determine whether the 
levels of IgA in milk collected from human volunteers 
at different points post-partum varied over time, as this 
could have implications related to the use of pooled milk 
in these VLBW infants, if IgA levels are, in fact, 
correlated with this protection. 
Methods: All milk IgA levels were determined using 
nephelometry. Time points ranged from 10 days post- 
partum (pp) through 7.5 months pp. All samples were 
tested with controls consisting of: an IVIG preparation 
of known IgA content, IgA negative serum, normal 
serum and PBS as a negative control. 
Results: There was IgA detectable in all samples from 
day 10 pp onward. (There were no available samples for 
days l-10). Levels of IgA were substantial at all time 
points, and did not drop off significantly through at least 
7.5 months pp. Specific IgA antibodies directed against 
tetanus toxin, PNPS, Haemophilus influenzae type B, and 
rotavirus were seen at all time points tested. 
Conclusions: IgA directed against specific pathogens 
is present in sizable amounts in breast milk over a 
prolonged period. It may be one of the components of 
breast milk responsible for the protection afforded 
VLBW neonates against NEC and sepsis. As it is present 
in significant levels for prolonged periods, pooled milk 
given to these infants may have the same beneficial 
effects previously documented for mother’s own milk, 
regardless of when, the milk was obtained post-partum. 
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Background: Primary immunodeficiency in children 
results in impaired immune responses to a number of 
vaccine-preventable infections. Secondary immuno- 
deficiencies are associated with many illnesses (eg human 
immunodeficiency virus (HIV) disease) and treatments 
(eg chemotherapy, haemopoietic stem cell transplants 
[HSCT], solid organ transplants [SOT]). The nature and 
kinetics of immune reconstitution post-HSCT, and the 
potentially lethal infectious complications of immuno- 
suppressive treatment, eg in SOT recipients, are well 
documented. Although opportunistic organisms are 
considered to pose the most serious infective threat to 
immunocompromised children, common bacterial and 
viral infections against which immunisations are 
available may also cause substantial morbidity or even 
death (eg pneumococcal infection late after HSCT or 
SOT). Many studies have documented significant 
reductions in specific antibody concentrations after 
HSCT, and restoration of protective titres in most 
children after reimmunisation. However, there is little 
published data about immunisation in other groups of 
immunocompromised children. Nevertheless, most such 
children are likely to benefit from continuation or 
commencement of active immunisation, provided 
certain live vaccines are avoided when appropriate. 
Unfortunately, proof of benefit in terms of reduced 
morbidity and mortality is not yet available. Despite 
broad recommendations concerning immunisations in 
these children, clinical practice varies considerably, 
particularly concerning the content and timing of 
immunisation schedules. 
A Working Party of the Royal College of Paediatrics 
and Child Health was asked to develop guidelines for 
the immunisation of immunocompromised children. 
Methods: Information was collated from formal com- 
puterised searches and personal knowledge of the 
literature, expert committee reports, and the clinical 
experience and practice of respected authorities. The 
paucity of controlled trials prevented development of 
evidence-based guidelines. Instead a “Best Practice 
Statement” (BPS) was written. 
Results: The BPS includes detailed recommendations 
for immunisation in children: (1) primary immuno- 
